Back to Search
Start Over
390P OriA362: A promising CLDN18.2/4-1BB bispecific antibody for targeting pancreatic and gastric cancers with high efficacy and safety profile.
- Source :
-
Annals of Oncology . 2024 Supplement 1, Vol. 35, pS157-S157. 1p. - Publication Year :
- 2024
- Subjects :
- *BISPECIFIC antibodies
*STOMACH cancer
*PANCREATIC cancer
*SAFETY
Subjects
Details
- Language :
- English
- ISSN :
- 09237534
- Volume :
- 35
- Database :
- Academic Search Index
- Journal :
- Annals of Oncology
- Publication Type :
- Academic Journal
- Accession number :
- 178046167
- Full Text :
- https://doi.org/10.1016/j.annonc.2024.05.531